1907
永豐餘
-0.15 (-0.52%)28.85556成交張數16.97本益比0.53股價淨值比3.47%殖利率2026-09-15資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入202573,643年增 -6.1%
毛利率202513.0%最新一期
營業利益率2025-1.1%最新一期
每股盈餘20251.19年增 +21.4%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 銷貨收入淨額 | – | +5.4% | +14.6% | -3.9% | -5.5% | +13.2% | +0.5% | -6.5% | +1.2% | -5.4% | |
| 其他營業收入淨額 | – | +5.3% | +13.5% | +10.9% | +20.4% | +33.3% | -37.5% | -12.1% | +42.9% | -9.4% | |
| 營業收入合計 | – | +5.4% | +14.5% | -2.2% | -2.0% | +16.5% | -6.6% | -7.2% | +6.2% | -6.1% | |
| 銷貨成本 | – | +3.0% | +18.3% | -5.5% | -8.6% | +14.3% | +5.8% | -6.3% | +2.3% | -5.5% | |
| 其他營業成本 | – | +10.2% | +17.7% | +10.6% | +11.8% | +21.5% | -20.6% | -12.0% | +43.4% | -7.0% | |
| 營業成本合計 | – | +3.7% | +18.2% | -3.9% | -6.3% | +15.3% | +2.0% | -6.9% | +6.6% | -5.7% | |
| 生物資產當期公允價值減出售成本之變動利益(損失) | – | – | – | – | – | +919.5% | -170.8% | – | – | -398.9% | |
| 營業毛利（毛損） | – | +14.0% | -2.7% | +7.5% | +19.3% | +21.2% | -38.8% | -9.3% | +3.4% | -8.5% | |
| 營業毛利（毛損）淨額 | – | +14.0% | -2.7% | +7.5% | +19.3% | +21.2% | -38.8% | -9.3% | +3.4% | -8.5% | |
| 推銷費用 | – | -10.1% | +4.7% | +6.2% | -2.8% | +8.8% | -1.7% | -1.2% | +8.1% | -2.6% | |
| 管理費用 | – | +2.8% | +0.6% | -4.2% | -3.3% | +3.5% | -0.6% | +1.6% | +2.9% | -0.9% | |
| 研究發展費用 | – | +59.7% | +13.0% | +37.5% | +23.9% | +39.7% | -8.8% | -2.4% | +13.7% | -1.7% | |
| 營業費用合計 | – | -3.8% | +3.1% | +2.6% | -2.0% | +8.1% | -1.7% | -0.2% | +6.4% | -2.0% | |
| 營業利益（損失） | – | +165.6% | -20.3% | +26.7% | +87.3% | +43.0% | -85.7% | -88.0% | -212.0% | – | |
| 利息收入 | – | – | – | – | – | -13.5% | +142.5% | +57.5% | +13.5% | +6.2% | |
| 其他收入 | – | -5.1% | +29.0% | +12.6% | +86.2% | -45.1% | -0.4% | -1.1% | +16.9% | +19.5% | |
| 其他利益及損失淨額 | – | – | – | – | – | – | – | – | +10.6% | +34.4% | |
| 財務成本淨額 | – | -0.7% | +9.7% | -8.8% | -25.1% | -22.0% | +58.8% | +23.1% | +5.1% | +10.5% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | -30.3% | +50.4% | -16.6% | +51.3% | +55.0% | +69.3% | -21.0% | +13.8% | +18.1% | |
| 營業外收入及支出合計 | – | – | – | -0.2% | +390.6% | -36.5% | +38.6% | -0.6% | +19.1% | +21.7% | |
| 稅前淨利（淨損） | – | +194.6% | +3.1% | +21.5% | +135.5% | +16.6% | -63.3% | -28.6% | +6.8% | -1.8% | |
| 所得稅費用（利益）合計 | – | +73.0% | +36.7% | -7.2% | +97.7% | +13.3% | -63.2% | -37.6% | +3.4% | +9.0% | |
| 繼續營業單位本期淨利（淨損） | – | +284.1% | -8.1% | +35.7% | +148.3% | +17.5% | -63.3% | -26.2% | +7.5% | -4.1% | |
| 本期淨利（淨損） | – | +284.1% | -8.1% | +35.7% | +148.3% | +17.5% | -63.3% | -26.2% | +7.5% | -4.1% | |
| 確定福利計畫之再衡量數 | – | – | -226.5% | – | +822.9% | -78.0% | -265.3% | – | -117.7% | – | |
| 透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益 | – | – | – | – | -100.1% | – | -47.8% | +57.1% | +74.8% | +72.4% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目 | – | – | – | – | -40.1% | +351.5% | -90.8% | +792.9% | +24.1% | +111.1% | |
| 不重分類至損益之項目： | – | – | – | – | -81.8% | +551.8% | -59.3% | +111.0% | +54.7% | +77.7% | |
| 國外營運機構財務報表換算之兌換差額 | – | – | – | -596.6% | – | – | – | -117.6% | – | -168.1% | |
| 避險工具之損益 | – | – | – | -85.1% | +13.3% | +304.6% | -100.0% | – | – | +66.5% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | – | – | – | – | -127.1% | – | -227.1% | |
| 後續可能重分類至損益之項目： | – | – | – | – | – | – | – | -119.1% | – | -170.9% | |
| 其他綜合損益（淨額） | – | – | – | – | -101.0% | – | +7.3% | -11.5% | +137.5% | +9.6% | |
| 本期綜合損益總額 | – | – | +55.4% | +146.1% | +26.6% | +71.6% | -41.3% | -17.8% | +87.4% | +6.6% | |
| 母公司業主（淨利∕損） | – | – | -10.4% | +58.7% | +127.9% | -0.1% | -58.3% | -15.8% | -10.7% | +21.0% | |
| 非控制權益（淨利∕損） | – | +22.5% | -1.1% | -28.1% | +273.1% | +83.4% | -73.5% | -59.6% | +129.0% | -69.5% | |
| 母公司業主（綜合損益） | – | – | +77.3% | +198.9% | +12.3% | +61.4% | -33.8% | -12.4% | +77.8% | +15.9% | |
| 非控制權益（綜合損益） | – | +152.4% | +12.4% | -17.7% | +188.0% | +116.3% | -65.7% | -51.8% | +197.0% | -57.3% | |
| 基本每股盈餘 | – | – | -10.3% | +58.6% | +127.5% | -0.3% | -58.1% | -16.0% | -10.9% | +21.4% | |
| 繼續營業單位淨利（淨損） | – | – | -10.3% | +58.6% | +127.5% | -0.3% | -58.1% | -16.0% | -10.9% | +21.4% | |
| 稀釋每股盈餘 | – | – | -10.3% | +58.6% | +127.5% | -0.3% | -58.1% | -16.0% | -10.9% | +21.4% | |
| 備供出售金融資產未實現評價損益 | – | – | -100.0% | – | – | – | – | – | – | – | |
| 現金流量避險中屬有效避險部分之避險工具利益(損失) | – | – | – | – | – | – | – | – | – | – | |
| 採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目 | – | – | – | – | – | – | – | – | – | – | |
| 其他收益 | – | – | – | – | – | – | – | – | – | – | |
| 其他收益及費損淨額 | – | – | – | – | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。